Advanced search
Publication Cover
Drug Delivery Volume 28, 2021 - Issue 1
Submit an article Journal homepage
3,826
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Preparation and characterization of paclitaxel palmitate albumin nanoparticles with high loading efficacy: an in vitro and in vivo anti-tumor study in mouse models

Hang Chena Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, ChinaView further author information
,
Sifan Huanga Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, ChinaView further author information
,
Heyi Wangb Department of Pharmacy, Inner Mongolia Medical University, Huhhot, ChinaView further author information
,
Xinmei Chena Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, ChinaView further author information
,
Haiyan Zhanga Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, ChinaView further author information
,
Youfa Xuc Shanghai Wei Er Biopharmaceutical Technology Co., Ltd, Shanghai, ChinaView further author information
,
Wei Fand Department of Pharmacy, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. ChinaView further author information
,
Yun Panc Shanghai Wei Er Biopharmaceutical Technology Co., Ltd, Shanghai, ChinaView further author information
,
Qiuyan Wenc Shanghai Wei Er Biopharmaceutical Technology Co., Ltd, Shanghai, ChinaView further author information
,
Zhizhe Linc Shanghai Wei Er Biopharmaceutical Technology Co., Ltd, Shanghai, ChinaView further author information
,
Xuena Wangc Shanghai Wei Er Biopharmaceutical Technology Co., Ltd, Shanghai, ChinaView further author information
,
Yongwei Guc Shanghai Wei Er Biopharmaceutical Technology Co., Ltd, Shanghai, ChinaView further author information
,
Baoyue Dinge School of Pharmacy, Jiaxing College, Jiaxing, ChinaView further author information
,
Jianming Chena Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China;b Department of Pharmacy, Inner Mongolia Medical University, Huhhot, ChinaCorrespondence[email protected]
View further author information
&
Xin Wua Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China;c Shanghai Wei Er Biopharmaceutical Technology Co., Ltd, Shanghai, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1067-1079 | Received 08 Mar 2021, Accepted 20 Apr 2021, Published online: 10 Jun 2021

References

  • Chung HJ, Kim HJ, Hong ST. (2020). Tumor-specific delivery of a PTX-loading HSA-haemin nanoparticle for cancer treatment. Nanomed Nanotechnol Biol Med 23:102089.
  • Dou T, Wang J, Han C, et al. (2019). Cellular uptake and transport characteristics of chitosan modified nanoparticles in Caco-2 cell monolayers. Int J Biol Macromol 138:791–9.
  • Duggett NA, Griffiths LA, Flatters SJL. (2017). PTX-induced painful neuropathy is associated with changes in mitochondrial bioenergetics, glycolysis, and an energy deficit in dorsal root ganglia neurons. Pain 158:1499–1508.
  • Gardner ER, Dahut W, Figg WD. (2008). Quantitative determination of total and unbound PTX in human plasma following Abraxane treatment. J Chromatogr B 862:213–8.
  • Hong W, Kim K, Jung Y, et al. (2012). 432 Comparison of Efficiency and Side Effect of Adriamycin and Doxetaxel and Adriamycin, Cyclophosphamide and PTX in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy. Eur J Cancer 48:S172–S173.
  • Itatani Y, Kawada K, Yamamoto T, et al. (2018). Resistance to anti-angiogenic therapy in cancer-alterations to anti-VEGF pathway. Int J Mol Sci 19:1232.
  • Kaddoumi A, Gill KK, Elfakhri K, et al. (2017). Development and qualification of an LC–MS/MS method for investigating the biological implications of micelle entrapped PTX in cell culture and rats. Biomed Chromatogr 31:e3960.
  • Karimi M, Avci P, Mobasseri R, et al. (2013). The novel albumin-chitosan core-shell nanoparticles for gene delivery: preparation, optimization and cell uptake investigation. J Nanopart Res 15:1651.
  • Karimi M, Gheybi F, Zamani P, et al. (2020). Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: In vitro and in vivo anti-tumor study. Int J Pharm 580:119211.
  • Kinoshita R, Ishima Y, Chuang VTG, et al. (2017). Improved anticancer effects of albumin-bound PTX nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer. Biomaterials 140:162–9.
  • Li F, Yuan H, Zhang H, et al. (2019). Neonatal Fc Receptor (FcRn) Enhances Tissue Distribution and Prevents Excretion of nab-PTX. Mol Pharmaceutics 16:2385–93.
  • Okamoto Y, Taguchi K, Sakuragi M, et al. (2019). Preparation, Characterization, and in Vitro/in Vivo Evaluation of PTX-Bound Albumin-Encapsulated Liposomes for the Treatment of Pancreatic Cancer. ACS Omega 4:8693–700.
  • Pandya AD, Jäger E, Fam SB, et al. (2019). PTX-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy. Int J Nanomed 14:6269–85.
  • Salehiabar M, Nosrati H, Javani E, et al. (2018). Production of biological nanoparticles from bovine serum albumin as controlled release carrier for curcumin delivery. Int J Biol Macromol 115:83–9.
  • Shahani K, Swaminathan SK, Freeman D, et al. (2010). Injectable sustained release microparticles of curcumin: a new concept for cancer chemoprevention. Cancer Research 70:4443–52.
  • Skwarczynski M, Hayashi Y, Kiso Y. (2006). PTX prodrugs: toward smarter delivery of anticancer agents. J Med Chem 49:7253–69.
  • Tai CJ, Huang MT, Wu CH, et al. (2016). Combination of two targeted medications (bevacizumab plus cetuximab) improve the therapeutic response of pancreatic carcinoma. Medicine(Baltimore) 95:e3259.
  • Tai CJ, Wang H, Wang CK, et al. (2017). Bevacizumab and cetuximab with conventional chemotherapy reduced pancreatic tumor weight in mouse pancreatic cancer xenografts. Clin Exp Med 17:141–50. ].
  • Thadakapally R, Aafreen A, Aukunuru J, et al. (2016). Preparation and characterization of PEG-albumin-curcumin nanoparticles intended to treat breast cancer. Indian Journal of Pharmaceutical Sciences 78:65–72.
  • Verco J, Johnston W, Baltezor M, et al. (2019). Pharmacokinetic profile of inhaled submicron particle PTX (NanoPac®) in a rodent model. J Aerosol Med Pulmon Drug Deliv 32:99–109.
  • Webster L, Linsenmeyer M, Millward M, et al. (1993). Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype. J Natl Cancer I 85:1685–90.
  • Xiong XY, Pan X, Tao L, et al. (2017). Enhanced effect of folated pluronic F87-PLA/TPGS mixed micelles on targeted delivery of PTX. Int J Biol Macromol 103:1011–8.
  • Yi X, Lian X, Dong J, et al. (2015). Co-delivery of pirarubicin and PTX by human serum albumin nanoparticles to enhance antitumor effect and reduce systemic toxicity in breast cancers. Mol Pharmaceutics 12:4085–98.
  • Yin T, Dong L, Cui B, et al. (2015). A toxic organic solvent-free technology for the preparation of PEGylated PTX nanosuspension based on human serum albumin for effective cancer therapy. Int J Nanomed 10:7397–412.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.